跳至主要内容
临床试验/NCT01595503
NCT01595503终止不适用

Functional Targeting of Transcranial Magnetic Stimulation for the Treatment of Refractory Auditory Hallucinations in Schizophrenia

University of Michigan1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2011年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
5
试验地点
1
主要终点
Change in Severity of Auditory Hallucinations

研究概览

简要总结

Repetitive transcranial magnetic stimulation (rTMS) is a new noninvasive therapy that uses magnetic energy applied to the scalp to modulate activity in the underlying regions of the brain. In this study we will examine the efficacy of treating auditory hallucinations in schizophrenia with rTMS, comparing two methods to target stimulation to a language processing region of the brain. One method targets the stimulation site using scalp landmarks, while the other uses functional magnetic resonance imaging (fMRI) combined with a language task.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Provide signed and dated informed consent form
  • •Male or female, aged 18 to 60
  • •Willing to comply with all study procedures and be available for the duration of the study
  • •Primary diagnosis of schizophrenia or schizoaffective disorder according to DSM-IV (29)
  • •Currently reporting AHs, rated a minimum of 4 (moderate) on the auditory hallucination item of the Brief Psychiatric Rating Scale (BPRS; 27), and AH will be present daily
  • •AHs must have failed to resolve after a minimum of two adequate trials (doses within standard therapeutic range for a minimum of 8 weeks each) of psychotropic medication including at least one atypical antipsychotic medication; documented trials of antipsychotic medication limited by intolerable side effects, e. g. extra-pyramidal symptoms, tardive dyskinesia, weight gain, neuroleptic-induced dysphoria, will also be considered as equivalent to adequate trials.
  • •Weight and girth compatible with the bore of the MRI scanner; generally men over 6 feet tall < 250 lbs, men under 6 feet tall < 220 lbs, women over 5'11" tall < 220 lbs, or women under 5'10" tall < 200 lbs

排除标准

  • •Substance abuse or dependence in the past 1 month
  • •Current or past history of serious medical or neurological illness that could compromise brain function or present an increased risk of seizure, e. g. conditions that may significantly alter electrolyte balance, stroke, epilepsy, any history of seizure;
  • •Pregnant or trying to become pregnant;
  • •Inability to tolerate small, enclosed spaces without anxiety;
  • •Metals, implants or metallic substances within or on the body that might cause adverse effects to the subject in a strong magnetic field, or interfere with image acquisition, e. g. aneurysm clips, retained particles, neurostimulators, foil-backed transdermal patches;
  • •Facial tattoos with metallic ink
  • •Inability to follow study protocol
  • •Change in antipsychotic therapy in previous 2 weeks
  • •Currently under an alternative treatment order
  • •Unstable symptoms which could, in the judgment of the study team, exhibit symptomatic worsening over the course of the protocol
  • •Current treatment with another investigational drug or other intervention
  • •Anything that, in the opinion of the investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study;
  • •No quantifiable motor threshold such that TMS dosage cannot be accurately determined

研究组 & 干预措施

landmark-based targeting

Active Comparator

干预措施: rTMS with landmark-based targeting (Procedure)

fMRI-based targeting

Experimental

干预措施: rTMS with fMRI-based targeting (Procedure)

结局指标

主要结局

Change in Severity of Auditory Hallucinations

时间窗: Two weeks

Hallucination Change Scale (Hoffman RE, Gueorguieva R, Hawkins KA, Varanko M, Boutros NN, Wu YT, et al. (2005): Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 58:97-104.) Baseline score, by definition: 10 Range: 0 (no hallucinations) to 20 (hallucinations twice as bad as baseline) Thus, a score of less than 10 means that hallucinations were reduced, whereas a score of greater than 10 means that hallucinations were increased.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephan F. Taylor

Professor of Psychiatry

University of Michigan

研究点 (1)

Loading locations...

相似试验